| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Le Ma | Q88023073 |
| P2093 | author name string | Jian Zhang | |
| Ming Zhang | |||
| Jun Liang | |||
| Xiao-Hong Liu | |||
| Mingxu Wang | |||
| P2860 | cites work | The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes. | Q52876472 |
| The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation. | Q53186858 | ||
| Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody. | Q53245556 | ||
| Antibodies against AT1-receptor in transplantation (diagnostics, treatment, clinical relevance). | Q53519017 | ||
| Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies | Q70222490 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology | Q80367574 | ||
| Transplantation 50 years later--progress, challenges, and promises | Q81191690 | ||
| Agonistic autoantibodies and rejection of renal allografts | Q81386151 | ||
| Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation | Q86990338 | ||
| The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes | Q88040407 | ||
| Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies | Q89275357 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
| Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor | Q33855316 | ||
| Diagnosis and prevention of chronic kidney allograft loss | Q34224452 | ||
| Proinflammatory actions of angiotensins. | Q34244757 | ||
| Pathways to acute humoral rejection | Q35096103 | ||
| Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. | Q36248631 | ||
| Donor-specific antibodies adversely affect kidney allograft outcomes. | Q36426146 | ||
| Antibody-mediated renal allograft rejection: diagnosis and pathogenesis | Q36759900 | ||
| β2-Adrenergic receptors in immunity and inflammation: stressing NF-κB. | Q38280243 | ||
| Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis | Q38771615 | ||
| Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies | Q39737548 | ||
| The AT1A receptor "gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II. | Q40342766 | ||
| Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period? | Q43408838 | ||
| Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss | Q43817587 | ||
| Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction | Q43939628 | ||
| Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months | Q44503859 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Kidney allograft survival after acute rejection, the value of follow-up biopsies | Q46211382 | ||
| Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies | Q46456694 | ||
| C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies | Q47571875 | ||
| Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan. | Q47608906 | ||
| Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies | Q47789001 | ||
| Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis | Q48577521 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P577 | publication date | 2017-05-09 | |
| P1433 | published in | International Journal of Environmental Research and Public Health | Q6051382 |
| P1476 | title | The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes | |
| P478 | volume | 14 |
| Q64897924 | Bilirubin, a new therapeutic for kidney transplant? |
| Q64939685 | Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies. |
| Q48160896 | Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study. |
Search more.